Riverbridge Partners LLC Bristol Myers Squibb CO Transaction History

Riverbridge Partners LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Feb 15, 2024	BUY	$57.89 - $64.73 $230,460 - $257,690	3,981 New	3,981 $231,000
Q1 2022 Apr 20, 2022	SELL	$61.48 - $73.72 $88,777 - $106,451	-1,444 Reduced 26.62%	3,981 $291,000
Q2 2021 Jul 26, 2021	SELL	$61.91 - $67.42 $1,300 - $1,415	-21 Reduced 0.39%	5,425 $362,000
Q1 2021 Apr 21, 2021	BUY	$59.34 - $66.74 $1,246 - $1,401	21 Added 0.39%	5,446 $344,000
Q4 2020 Jan 22, 2021	SELL	$57.74 - $65.43 $23,096 - $26,172	-400 Reduced 6.87%	5,425 $337,000
Q4 2017 Jan 24, 2018	BUY	$59.94 - $65.35 $349,150 - $380,663	5,825	5,825 $357,000

2,428

1.5B

29.7M

32.2M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $113B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of Riverbridge Partners LLC, based on Form 13F filings with the SEC.

Stay updated on Riverbridge Partners LLC with notifications on news.